Adverse Event Reporting Rule Draws Concern About FDA's Electronic Readiness
Executive Summary
FDA's planned move to mandatory electronic filing of adverse event reports is raising some concern about its cost to small business and the agency's ability to fully integrate its growing number of electronic filing requirements
You may also be interested in...
Adverse Event Rule Would Require e-Conversion Of 20 Percent Of Submissions
FDA's proposed rule to require electronic submission of adverse event information would mandate a switch that industry already seems to be making rapidly
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials